Relay Medical Presents Pharmatrac Countertop Medication Device; Provides Development Update
Toronto, Ontario--(Newsfile Corp. - February 18, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to provide an update on Pharmatrac development activities and present the Pharmatrac Countertop Medication Device. The Pharmatrac System is being developed to offer sophisticated solutions to improve medication management for patients, caregivers and other stakeholders in the healthcare environment. The...
2020-02-18 4:05 PM EST
Relay Medical Closes $945,000 Debt Financing
Toronto, Ontario--(Newsfile Corp. - January 29, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company completed a financing of $945,000 through the issuance of secured convertible debentures (the "Debentures"). The Debentures will mature on the first anniversary of issuance (the "Maturity Date") and bear interest at a rate of ten percent (10%) per annum which shall accrue from...
2020-01-29 7:58 PM EST
Update: Relay Medical Joint Spectroscopic and Biosensor System for Point-of-Care Testing Patent Granted in China
Toronto, Ontario--(Newsfile Corp. - January 7, 2020) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company") is pleased to announce an update to September 11th news release regarding the approval for grant of Chinese Patent Application No. 201580025752.6. The company has been informed that the patent has been officially granted by the Chinese patent authority as patent number CN106716137B with an expiry date of May 20, 2035. This new patent continues to expand...
2020-01-07 4:00 PM EST
Relay Medical Announces Extension of Warrant Expiry Date
Toronto, Ontario--(Newsfile Corp. - October 25, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, announces that it intends to extend the expiry date of an aggregate of 7,570,500 previously issued warrants (the "Warrants") at an exercise price of $0.30 for an additional twelve (12) months (the "Amendment"). The exercise price of the Warrants will remain unchanged. About Relay Medical Corp. Relay Medical is an...
2019-10-25 4:39 PM EDT
Relay Medical Announces HemoPalm(TM) Multi-Product Expansion; Formation of HemoPalm Corp. IVD Subsidiary
Toronto, Ontario--(Newsfile Corp. - September 23, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to announce the expansion of the Company's HemoPalm IP into a multi-product family, and formation of the In Vitro Diagnostics (IVD) wholly-owned subsidiary, HemoPalm Corp., part of the Relay Medical Group of Companies. HemoPalm Corp. has been established to accelerate the development and commercialization...
2019-09-23 3:00 AM EDT
Relay Medical Forms Osprey Device Networks Corp. for Point-of-Care Medical Device Fleet and Data Management
Toronto, Ontario--(Newsfile Corp. - September 17, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the creation of Osprey Device Networks Corp. ("Osprey" or "ODN"), a wholly-owned subsidiary of the Company to commercialize products and services related to the management of decentralized fleets of medical devices and the data streams they produce. On July 2nd, 2019 Relay Medical Corp reported...
2019-09-17 4:19 PM EDT
Relay Medical Joint Spectroscopic and Biosensor System for Point-of-Care Testing Patent Approved for Grant in China
Toronto, Ontario--(Newsfile Corp. - September 12, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to announce that it has received formal notice that Patent Application No. 201580025752.6 for Joint Spectroscopic and Biosensor System for Point-of-Care Testing has been approved for grant in China, filed internationally May 20, 2015. Relay Medical's Joint Spectroscopic and Biosensor System for...
2019-09-12 4:06 PM EDT
Relay Medical Announces Closing of Second Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - August 9, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company has completed the second tranche of the private placement financing (the "Offering") for gross proceeds of $542,000 through the issuance of 2,710,000 Units (each, a "Unit") at a price of $0.20 per unit. The aggregate gross proceeds raised pursuant to the first and second tranches...
2019-08-09 5:00 PM EDT
Relay Medical Acquires License to Medical-Grade Cloud Software from Fio Corporation
Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the acquisition of rights to a medical-grade cloud software platform, from Fio Corporation, which develops sophisticated healthcare IT solutions for decentralized and mobile settings across the continuum of care, globally. The software, to be marketed as Relay MedNet, has been acquired to...
2019-07-02 4:30 PM EDT
Relay Medical Develops Pharmatrac Swift, a Plug and Play Solution for Tracking of High Value Medications
Toronto, Ontario--(Newsfile Corp. - June 27, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on extensions to the Pharmatrac platform to address the challenge of tracking expensive medications that are compromised if not properly stored. Highlights: Extended digital medication label design to accommodate blister packs, to broaden the medication packaging form factors with which Pharmatrac is...
2019-06-27 9:44 PM EDT
Relay Medical Appoints Moshe Katzenelson as Senior Vice President, Global Business Development
Toronto, Ontario--(Newsfile Corp. - June 26, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of Moshe Katzenelson as Senior Vice President, Global Business Development. For over 25 years Mr. Katzenelson has played a pivotal role in the advancement of high-tech innovation in Israel's burgeoning technology industry and bringing that innovation to international markets through...
2019-06-26 4:05 PM EDT
Relay Medical Announces Closing of Private Placement for Proceeds of Over $1.5M
Toronto, Ontario--(Newsfile Corp. - May 17, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the closing of a private placement financing (the "Offering") for gross proceeds of $1,532,500 through the issuance of 7,662,500 Units (each, a "Unit") at a price of $0.20 per unit. Each Unit is comprised of: (i) one common share in the capital of the Company (each a "Common Share"); (ii) one Common...
2019-05-17 5:00 PM EDT
Relay Medical Commences Second Pharmatrac User Study and Reports on Development Activities
Toronto, Ontario--(Newsfile Corp. - May 16, 2019) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, reports on Pharmatrac development activities and the commencement of a user study on the Pharmatrac in-home countertop medication appliance. In early February the Company reported on the Pharmatrac digital medication label hardware design following the completion of the first Relay-led user study. Following further business...
2019-05-16 4:05 PM EDT
Relay Medical Reports on Technical Advancement of HemoPalm System
Toronto, Ontario--(Newsfile Corp. - May 14, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on technical advances of the Company's enhanced HemoPalm point-of-care (POC) testing platform. Development Highlights: Demonstrated feasibility of whole blood analysis: The Company's proprietary optical approach has demonstrated accurate measurement of hemoglobin fractions (compared with...
2019-05-14 4:05 PM EDT
Relay Medical Strengthens Board of Directors with Established Software, Financial and Pharma Executives
Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce Messrs. Sid Thomas, Medhanie Tekeste and Greg Van Staveren as new appointments to the Company's Board of Directors. The appointments are effective immediately. These appointments are consistent with the Company's expansion and advancement as an integrated MedTech innovator developing technologies for...
2019-04-01 2:55 AM EDT
Paul Glavina Joins Relay Medical and HemoPalm Team as Vice President, In Vitro Diagnostics
Toronto, Ontario--(Newsfile Corp. - February 13, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company”), an engine of MedTech innovation, is pleased to announce the appointment of Paul Glavina as Vice President, In Vitro Diagnostics, of Relay Medical Corp. Paul is a veteran leader of more than 30 years in the application of biosensors at the point of patient care (“Point of Care Testing”, POCT). As Relay’s Vice President, In Vitro Diagnostics (IVDs), he...
2019-02-13 3:00 AM EST
Relay Medical Announces Pharmatrac Digital Label Design and Development Activities
Toronto, Ontario--(Newsfile Corp. - February 11, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on development activities and hardware design on the Pharmatrac medication management technology. Following the completion of the first Relay led Pharmatrac user study, the Company is pleased to present the Pharmatrac's digital label hardware design. In November 2018 the Company announced the...
2019-02-11 4:10 PM EST
Relay Medical Reports Progress on Enhanced HemoPalm System Design and Provides Update on Product Development and Market Advancement Activities
Toronto, Ontario--(Newsfile Corp. - February 7, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the advancement of the Company's HemoPalm technology and Relay's enhanced HemoPalm system design as well as market advancement activities as the Company continues to build toward productization of this unique point-of-care (POC) testing platform. Relay is developing the HemoPalm technology to...
2019-02-07 2:55 AM EST
Relay Medical Provides 2018 Overview
Toronto, Ontario--(Newsfile Corp. - February 4, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an overview of operations and developments for 2018. In 2018 Relay Medical made significant advances to the company's business and capabilities, notably changing the leadership, defining and refining the business model, expanding the techno-commercial team, building relevant infrastructure,...
2019-02-04 2:55 AM EST
Relay Medical Appoints Executives; John Soloninka Appointed Senior Vice-President, Acquisitions and Exits; Yoav Raiter as Director, Product Development
Toronto, Ontario--(Newsfile Corp. - December 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of John Soloninka as Senior Vice-President of Acquisitions and Exits and Yoav Raiter as Director of Product Development. The appointments have been made in support of the Company's multi-project integrated accelerator model. John Soloninka is a seasoned MedTech executive with over...
2018-12-13 4:05 PM EST